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Abstract
Background: Cardiac resynchronization Therapy (CRT) is an effective therapy for chronic heart failure with
beneficial hemodynamic effects leading to a reduction of morbidity and mortality. The responder rates, however,
are low. There are various and contentious echocardiographic parameters of myocardial asynchrony. Patient
selection by echocardiographic assessment of asynchrony is thought to improve responder rates.
Methods: In this small single-center pilot-study, seven established parameters of myocardial asynchrony were
used to select patients for CRT: (1) interventricular electromechanical delay (IMD, cut-off ≥ 40 ms), (2) Septal-
to-posterior wall motion delay (SPWMD, ≥ 130 ms), (3) maximal difference in time-to-peak velocities between
any two of twelve LV segments (Ts-12 ≥ 104 ms), (4) standard deviation of time to peak myocardial velocities
(Ts-12-SD, ≥ 34.4 ms), (5) difference between the septal and basal time-to-peak velocity (TDId, ≥ 60 ms), (6) left
ventricular electromechanical delay (LVEMD, > 140 ms) and (7) delayed longitudinal contraction (DLC, > 2
segments).
16 chronic heart failure patients (NYHA III–IV, LVEF < 0.35, QRS ≥ 120 ms) at least two out of seven parameters
of myocardial asynchrony received cardiac resynchronization therapy (CRT-ICD). Follow-up echo examination
was after 6 months. The control group was a historic group of CRT patients (n = 38) who had not been screened
for echocardiographic signs of myocardial asynchrony prior to device implantation.
Results: Based on reverse remodeling (relative reduction of LVESV > 15%, relative increase of LVEF > 25%), the
responder rate to CRT was 81.2% in patients selected for CRT according to our protocol as compared to 47.4%
in the control group (p = 0.04). At baseline, there were on average 4.1 ± 1.6 positive parameters of asynchrony
(follow-up: 3.7 [± 1.6] parameters positive, p = 0.52). Only the LVEMD decreased significantly after CRT (p =
0.027). The remaining parameters showed a non-significant trend towards reduction of myocardial asynchrony.
Conclusion: The implementation of different markers of asynchrony in the selection process for CRT improves
the hemodynamic response rate to CRT.
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Cardiac resynchronization Therapy (CRT) is an effective
therapy for chronic heart failure with beneficial hemody-
namic effects and a reduction of morbidity and mortality
[1-7]. Despite the overall favorable effect of CRT and a
lack of a clear definition of hemodynamic benefit, pub-
lished responder rates in the large CRT studies are low
(43–69%) [8-10]. In the CARE-HF study, only about 50%
of the patients responded clinically. The COMPANION
study [1] did not publish responder rates (2004).
In the CARE-HF study [6] with an observation period of
18 months, about half of the CRT patients had worsening
of heart failure, 21% died (of any cause), and 13% had
complications caused by CRT (e.g., lead displacement,
pneumothorax, infection, dissection, and one implanta-
tion-related death). Furthermore, as CRT is an expensive
therapy with relatively high complication rates, careful
patient selection and definition of predictors are needed.
Accounting for the complexity of the parameters of asyn-
chrony and the lack of a clear predictor, the indications for
CRT in the current guidelines do not include echo param-
eters of myocardial asynchrony [11] and an expert state-
ment of the ASE justifies patient selection by echo only in
borderline cases [12].
There is no diagnostic gold standard to determine myocar-
dial asynchrony. Echocardiography is considered as an
objective tool to evaluate myocardial intra- and interven-
tricular asynchrony. However, when assessing myocardial
asynchrony, some parameters cannot be reliably meas-
ured in all patients. Integrating multiple parameters might
therefore improve the diagnostic sensitivity and specificity
of asynchrony tests in the individual patient.
The goal of this pilot study was to improve the response
rate to CRT by prospective patient selection by echocardi-
ography.
Methods
This is a prospective single center study evaluating the
improvement of CRT response by implementing a new
echocardiographic approach in patient selection for CRT-
ICD.
Patients
Inclusion criteria were: chronic heart failure in the func-
tional classes NYHA III-IV with a LVEF < 0.35, QRS > 120
ms and at least two positive echo parameters of myocar-
dial asynchrony (combination of two intraventricular or
combination of one inter- and one intraventricular
parameter). Patients with more than two myocardial seg-
ments of akinesia (suggesting scar tissue) or left ventricu-
lar aneurysms (end-diastolic thinning of the myocardium
< 5 mm) were excluded from this study.
In order to obtain unbiased data regarding cardiac
improvement, standard and individually optimized heart
failure medication (including beta blockers, ACE inhibi-
tors or AT-1 receptor blockers at the maximally tolerated
dose and spironolactone, 25 mg/d) remained unchanged
3 months prior to implantation of CRT in all patients. Fol-
low-up was performed after 6 months.
The historic control group (n = 38) comprised patients
from our hospital that had received CRT in recent years.
The inclusion criteria for these patients were identical:
NYHA III-IV with a LVEF < 0.35 and a QRS width > 120
ms. All patients received a CRT- ICD and were fully docu-
mented by 2D and Tissue Doppler echocardiography at
baseline. The CRT patients underwent 6 months follow-
up examination, including echocardiography.
The AV-interval was set individually in all patients accord-
ing to [13]. There was no V-V-delay in all patients.
Echocardiography
Echocardiography was performed on a Vivid 7 (GE
Vingmed, Horton, Norway). The images were stored dig-
itally and analyzed off-line by EchoPac PC Dimension
(GE Vingmed, Horton Norway). For TDI and 2D echocar-
diography analysis, three beats were stored.
Seven parameters of intra- and interventricular asyn-
chrony were used [see table 1]. The parameters were cho-
sen according to their previous evaluation in larger CRT
studies. Furthermore, these parameters should be repro-
ducible and technically easy to measure. If more than two
of the seven parameters were positive, the patients
received CRT.
The interventricular electromechanical delay (IMD) is the
time difference between the left ventricular and right ven-
tricular electromechanical delays (i.e., the interval from
the beginning of the QRS complex to the beginning of
ejection in the pulmonary/aortic ventricular outflow
tract). The cut-off value for interventricular asynchrony is
> 40 ms [[6], additional file 1].
The septal-to posterior wall motion delay (SPWMD) is
obtained from M-mode in the parasternal long axis as the
shortest interval between the maximal contraction of the
septum and the maximal contraction of the left posterior
wall. The cut-off value for interventricular asynchrony is ≥
130 ms [[14,15], additional file 2].
The maximal difference in time-to-peak velocities
between any two of twelve LV segments (Ts-12) and thePage 2 of 10
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(Ts-12-SD) are assessed with Tissue Synchronization
Imaging (TSI). 12 myocardial segments in the apical views
(apical 4-chamber, 2-chamber and long-axis view) are
analyzed. These parameters with a cut-off value ≥ 34.4 ms
(Ts-12-SD) and ≥ 104 ms (Ts-12) were previously pre-
scribed as powerful predictors of response to CRT [[16],
additional file 3,4]
The difference between the basal septal and basal lateral
Ts is assessed with TDI in the apical four chamber view by
color-coded TDI (TDId). The cut-off value ≥ 60 ms is a
predictor of successful CRT [[17], additional file 5].
The left ventricular electromechanical delay (LVEMD) or
aortic pre-ejection delay is measured as the time between
the onsets of the QRS to aortic flow. The cut-off value of
this parameter is > 140 ms indicating intraventricular
asynchrony [[6], additional file 6].
The delayed longitudinal contraction (DLC) is assessed
with tissue tracking in the apical four chamber, two cham-
ber and long-axis views for the detection of LV segments
with mechanical asynchrony. The highest possible frame
rate was chosen according to [[17], additional file 7]. We
considered two and more segments with DLC as indica-
tive of asynchrony.
According to previous studies, we defined successful
resynchronization therapy as a relative reduction of the LV
end-systolic volume of more than 15% and a relative
increase of the LVEF of more than 25% compared to base-
line [19-21]. The latter has been evaluated in a follow-up
interval of 6 months. The LVEF and left-ventricular vol-
umes were calculated according to Simpson's rule [22].
Written consent was obtained from each patient, and the
ethics committee of the Charité University Hospital
approved the protocol.
Statistics
Statistics were calculated using SPSS (version 12.0, Chi-
cago, Ill, USA). Results are expressed as mean (± standard
deviation). Comparisons of non-parametric variables
between the "echo-guided CRT" patients and the control
group were calculated by Wilcoxon test. The comparison
of echocardiographic parameters between groups was cal-
culated by unpaired Whitney-Mann test. Dichotomized
data were analyzed by the Chi2-test. The level of signifi-
cance was p ≤ 0.05.
Results
16 patients with more than two positive echocardio-
graphic parameters of asynchrony received an ICD-CRT
("echo-guided CRT" group).
The historic controls (n = 38) were chosen because of the
complete echocardiographic follow-up at 6 months after
CRT. The controls did not differ in regard to their baseline
data: age, baseline QRS width and LVEF. However, there
Table 1: Echocardiographic parameters of myocardial asynchrony used to determine the presence of relevant asynchrony.
Parameter Definition Cut-off Ref. Example
Interventricular electromechanical delay (IMD) Interventricular electromechanical delay between 
pulmonary and aortic outflow. Measured as the time 
between the onset of the QRS to onset of aortic flow vs. 
QRS to onset of pulmonary flow
≥ 40 ms 6 1
Septal-to-posterior wall motion delay (SPWMD) M-mode: the interval between the maximum contraction 
of the septum and the maximum contraction of the left 
ventricular posterior wall
≥ 130 ms 14, 15 2
Ts-12 Maximum difference in Ts between any 2 of 12 LV 
segments
≥ 104 ms 16 3
Ts-12-SD Standard deviation of the time to peak myocardial 
velocity (Ts) of the 12 LV segments
≥ 34.4 ms 16 4
Septal-to-lateral delay in peak systolic velocity (TDId) Delay between the basal septal and basal lateral Ts, 
assessed with color-coded TDI
≥ 60 ms 17 5
LVEMD aortic pre-ejection delay measured as the time between 
the onset of the QRS to beginning aortic flow
> 140 ms 6 6
Delayed longitudinal contraction (DLC) Number of LV segments with DLC assessed by tissue 
tracking in the apical 4-chamber, 2-chamber and long-axis 
view
≥ 2 18 7Page 3 of 10
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(Table 2)
The echo-guided CRT-group had 4.1 ± 1.6 positive param-
eters of asynchrony at baseline (Table 3, figure 1, 2). After
6 months of CRT, 3.7 (± 1.6) parameters were positive (p
= 0.52). Only the LVEMD decreased significantly after
CRT (p = 0.027). The remaining parameters showed a
non-significant trend towards reduction of myocardial
asynchrony.
There was a clinical improvement in the echo-guided CRT
group (baseline NYHA 3.1 ± 0.25, NYHA 1.8 [± 1.0] after
CRT, p = 0.02). The responder rate in the "echo-guided
CRT" group was 81.2% compared to 47.4% in the control
group (p = 0.04). The reverse remodeling after CRT was
significant in both groups (figure 3). Mitral regurgitation
decreased in the echo-guided CRT group (2.2 ± 0.8 to 1.8
± 0.023 after CRT, p = 0.023), whereas there was no signif-
icant change in the control group.
ROC analysis for the 7 parameters (value above cut-off
measurements for asynchrony) to predict CRT benefit is
presented as area-under-the-curve: IMD: AUC = 0.58, p =
0.612; SPWMD: AUC 0.46, p = 0.71; TDId: AUC 0.63, p =
0.79; DLC AUC 0.60, p = 0.93; Ts-12 AUC = 0.88, p =
0.25; LVEMD AUC 0.56, p = 0.33, TS-12-SD AUC = 0.88 p
= 0.01.
Intra- and interobserver variability was calculated by the
intra-class correlation coefficient (ICC). There were good
correlations for Tissue Doppler measurements (ICC =
0.94, p < 0.001 and 0.96, p < 0.001, respectively).
Discussion
The main result of this prospective pilot study is that pro-
spective assessment of multiple echocardiographic
parameters of asynchrony increases the success rate of
CRT.
In most large studies, patient selection was solely based
on QRS width and NYHA class. Patient selection by
echocardiographic parameters of asynchrony was only
performed in a subset of studies for borderline cases [6,8].
The predictors of successful CRT are heterogeneous and
include a variety of clinical and echocardiographic param-
eters.
How can the improved responder rate in our study be
explained? Firstly, as myocardial asynchrony is a complex
phenomenon, every single parameter reflects one aspect
of this pathology. Our parameters evaluate inter- and
intraventricular asynchrony, 2D as well as TDI-echocardi-
ography. Therefore, integrating different parameters in the
selection process increases the chance to select patients
with relevant asynchrony for CRT.
Secondly, the improved response rate could be due to the
single center design and the careful patient assessment
and low inter- and intra-observer-variability. TDI meas-
urements are susceptible to observer variability, subjective
assessment of the curves and individual learning curves.
Table 2: Baseline patient characteristics (Differences between groups by Whitney-Mann test, Dichotomized data were analyzed by the 
Chi2-Pearson-Test)
echo-guided CRT group controls p
n = 16 38
% ischemic cardiomyopathy (ICMP) 37.5 (n = 5) 21.1 (n = 8) 0.49
Age [years] 67.1 (± 9.9) 63.6 (± 10.8) 0.79
male % 93.8 (n = 15) 68.4 (n = 26) 0.04
QRS width [mm] at baseline 166 (± 13) 165 (± 18) 0.48
Follow-up-interval [months] 6.7 (± 7.2) 9.4 (± 3.0) < 0.001
LVEF [%] 23.1 (± 6.7) 24.5 (± 7.4) 0.75
LV-EDV [ml] 259.1 (± 111.2) 262.0 (± 104.8) 0.98
LV-ESV [ml] 199.04 (± 89.4) 204.3 (± 90.8) 0.38
% responder according to reduction of LVESV/increase in EF 13/16 = 81.2% 18/38 = 47.4% 0.04Page 4 of 10
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CRT as in the PROSPECT study. Different echo machines
and unclear definition of echo parameters might also have
contributed to disappointing results.
Thirdly, to our experience, it is difficult to rely on one
parameter alone because, for example, the SPWD cannot
be measured in patients with previous anterior and septal
myocardial infarction. Furthermore, reduced acoustic
windows limit certain measurements frequently.
In our study, most parameters showed a non-significant
trend of improvement. This could be due to the small
patient number in our study. But this might also indicate
that a single parameter does not have enough power to
predict response to CRT.
Two large studies have analyzed echocardiography in the
prediction of CRT success: The PROSPECT and Re-THIN-
Q study [8,9]. The parameters used in the PROSPECT
study included SPWMD, IMD, left ventricular filling time
in  relation to cardiac cycle length, LVEMD, TDId, and Ts-
SD. These were comparable to the parameters used in this
study. The negative result of the PROSPECT study (no sin-
gle echo parameter can predict response to CRT) might
have been caused by a high inter-core-lab variability
(range 6.5–72.1%) that potentially blurred the role of
echocardiography.
Percentage of positive findings of asynchrony parameters at baseline (white bars) and after 6 months of CRT (black bars)Figure 1
Percentage of positive findings of asynchrony parameters at baseline (white bars) and after 6 months of CRT (black bars). The 
cut-offs for each parameter are listed in table 1.Page 5 of 10
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Times and delays in milliseconds at baseline (white bars) and after CRT (black bars)F gure 2
Times and delays in milliseconds at baseline (white bars) and after CRT (black bars). Mean ± SD. Data for DLC not shown (see 
table 4).
Table 3: Hemodynamic changes after CRT in the "echo-guided CRT group" and the control group.
echo-guided CRT group Controls
baseline Post CRT p baseline Post CRT p P (control vs. new post)
LVEF [%] 23.1 (± 6.7) 36.9 (± 11.2) 0.002 24.5 (± 7.4) 30.2 (± 10.2) 0.002 0.04
LV-ESV [ml] 204.3 (± 90.8) 153.8 (± 89.6) 0.023 262.0 (± 104.8) 199.0 (± 89.4) 0.030 0.378
LV-EDV [ml] 262.0 (± 104.8) 232.5 (± 104.5) 0.352 204.3 (± 90.8) 247.6 (± 119.7) 0.187 0.574
Amount of positive echo 
parameters of asynchrony
4.1 (± 1.6) 3.7 (± 1.6) 0.525 n.a. n.a.
Cardiovascular Ultrasound 2008, 6:58 http://www.cardiovascularultrasound.com/content/6/1/58The success rate of CRT is low (50.3–63.0%) when
defined by LVESD reduction [9]. The PROSPECT study
design did not prospectively select patients according to
presence of mechanical asynchrony but compared differ-
ent echo parameters of asynchrony in their predictive
value. In contrast, in our study, only patients with at least
two positive findings of myocardial asynchrony were
included to receive CRT.
The Re-THIN-Q study [8] evaluated CRT in patients with
thin QRS complexes and evidence of mechanical asyn-
chrony in Tissue Doppler imaging. The primary endpoint
was increase in peak oxygen consumption of at least 1.0
ml/kg KG/min after 6 months. The response rate to CRT –
defined as an increase in peak oxygen consumption – was
43%. In Re-THIN-Q, only two echo parameters were
assessed to measure asynchrony (TDI derived mechanical
delay in the septal-to-lateral and anteroseptal-to-posterior
walls and the septal-to-posterior wall delay in M-mode).
The TDI derived criterion was positive in 96% of patients,
the M-mode derived criterion only in 4% of patients. The
primary endpoint of the study was only met by the
patients with QRS ≥ 120 ms. The echocardiographic
parameters did not differ significantly in the responder
and non-responder groups indicating that echo did not
have a predictive value to select patients for CRT.
Which parameters contribute to patient selection for CRT?
The optimal technology to measure myocardial asyn-
chrony is still in debate. There is increasing concern about
asynchrony measurement by TDI-velocity because of dou-
ble-peaks and beat-to-beat variability of the curves which
are subject to tethering and translational motion. Hence,
some authors have suggested that strain and 2D strain
derived measurements of asynchrony (which reflect local
contractility) might have a higher prognostic value [23-
25]. A recent study has shown an overlap of TDI-derived
asynchrony parameters used in the large CRT studies in
healthy controls and heart failure patients with LBBB [25].
This underlines that the current cut-offs need verification.
Our study did not use 2D strain parameters for the detec-
tion of asynchrony but focused on parameters that were
established in large clinical trials.
The study by Bleeker [26] suggested that myocardial scar
burden and transmurality of the scar predicts CRT out-
come. In our study, we did not systematically screen the
patients by MRT prior to CRT implantation. However, we
excluded patients with akinesia in more than two seg-
ments, myocardial aneurysms or left ventricular thinning
in baseline echocardiography.
Suboptimal lead position can contribute to non-success-
ful CRT. Studies have shown that optimal lead position in
the site of the latest myocardial activation can improve the
echocardiographic and clinical results [27,28]. In our
study, the LV-lead position was not individually posi-
tioned. We aimed to implant the LV-lead in the postero-
lateral coronary sinus vein in all patients.
Conclusion
In summary, we conclude that the implementation of dif-
ferent markers of asynchrony seems to improve the hemo-
dynamic response rate in this small single center study. To
further support our findings, larger prospective, control-
led and randomized multi-center studies will have to be
Table 4: Change of asynchrony parameters (pre-post) in the 
echo-guided CRT group, p (Wilcoxon test)
Parameter baseline post CRT p
IMD [ms] 54.7 (± 26.8) 34.4 (± 23.8) 0.091
SPWMD [ms] 129.5 (± 106.3) 127.1 (± 53.2) 1.00
Ts-SD [ms] 56.1 (± 40.5) 48.5 (± 30.0) 0.691
Ts-12 [ms] 164.4 (± 91.8) 144.9 (± 66.1) 0.569
TDId [ms] 100.9 (± 71.4) 74.1 (± 61.5) 0.235
LVEMD [ms] 159.5 (± 30.7) 126.2 (± 49.0) 0.027
DLC [n] 1.7 (± 1.0) 1.3 (± 1.0) 0.394
Echocardiographic improvement after CRT: Individual LVEF at baseline and after CRT in the in he echo-guide  CRT group (n = 16, solid lines)Fig r  3
Echocardiographic improvement after CRT: Individual LVEF 
at baseline and after CRT in the in the echo-guided CRT 
group (n = 16, solid lines). The mean LVEF (± SD) in the 
echo-guided CRT group is shown in black (dashes line) and 
for the controls in grey (dotted line).Page 7 of 10
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parameters.
Limitations
This is a small pilot study performed in a single center.
Due to the small number of patients, no multivariate
analysis of the several parameters and no calculation of
predictive values could be performed. We have not sys-
tematically examined myocardial scar burden by cardiac
MRI prior to CRT implantation. The choice of echo
parameters should include parameters of three-dimen-
sional echo as well as parameters of radial and circumfer-
ential asynchrony. This was not done because the software
and equipment was not available for all patients.
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Measurement of the IMD in the aortic and the pulmonary outflow tracts.




M-mode in the paarasternal long axis to determine SPWMD.




Assessment of Ts12 and Ts-12-SD by TSI.




TSI: Patient with asynchrony in the lateral wall (apical four chamber 
view).




TDId in a healthy control and the asynchrony of myocardial contraction 
in the septal and lateral basal segments.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1476-
7120-6-58-S5.jpeg]
Table 5: Accessibility of the asynchrony parameters at baseline and after CRT. Chi2 test (p)
Parameter baseline Positive (%) post CRT Positive (%) p
IMD [ms] 13 6/46.2% 15 2/13.3% 0.773
SPWMD [ms] 13 6/46.2% 14 7/50.0% 0.559
Ts-SD [ms] 16 10/62.5% 16 12/75.0% 0.119
Ts-12 [ms] 16 10/62.5% 16 13/81.3% 0.838
TDId [ms] 15 9/60.0% 15 8/53.3% 0.551
LVEMD [ms] 15 12/80.0% 16 6/37.5% 0.869
DLC [n] 16 11/68.8% 15 9/60.0% 0.171Page 8 of 10
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